{"id":"https://openalex.org/W1862857558","doi":"https://doi.org/10.1046/j.1471-4159.2003.01621.x","title":"Effects of l \u2010dopa and other amino acids against paraquat\u2010induced nigrostriatal degeneration","display_name":"Effects of l \u2010dopa and other amino acids against paraquat\u2010induced nigrostriatal degeneration","alternate_titles":[],"publication_year":2003,"publication_date":"2003-02-28","ids":{"openalex":"https://openalex.org/W1862857558","doi":"https://doi.org/10.1046/j.1471-4159.2003.01621.x","mag":"1862857558","pmid":"https://pubmed.ncbi.nlm.nih.gov/12641729"},"language":"en","primary_location":{"id":"doi:10.1046/j.1471-4159.2003.01621.x","doi":"https://doi.org/10.1046/j.1471-4159.2003.01621.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.2003.01621.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1862857558"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010159066","display_name":"Alison L. McCormack","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165996","display_name":"Parkinson's Institute and Clinical Center","ror":"https://ror.org/05w1mrz55","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210165996"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alison L. McCormack","raw_affiliation_strings":["The Parkinson's Institute, Sunnyvale, California 94089, USA","The Parkinson's Institute, Sunnyvale, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Parkinson's Institute, Sunnyvale, California 94089, USA","institution_ids":["https://openalex.org/I4210165996"]},{"raw_affiliation_string":"The Parkinson's Institute, Sunnyvale, California, USA","institution_ids":["https://openalex.org/I4210165996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035849217","display_name":"Donato A. Di Monte","orcid":"https://orcid.org/0000-0002-8296-836X","observed_orcids":["https://orcid.org/0000-0002-8296-836X"]},"institutions":[{"id":"https://openalex.org/I4210165996","display_name":"Parkinson's Institute and Clinical Center","ror":"https://ror.org/05w1mrz55","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210165996"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Donato A. Di Monte","raw_affiliation_strings":["The Parkinson's Institute, Sunnyvale, California, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Parkinson's Institute, Sunnyvale, California, USA","institution_ids":["https://openalex.org/I4210165996"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5035849217"],"corresponding_institution_ids":["https://openalex.org/I4210165996"],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":3.1883,"has_fulltext":false,"cited_by_count":153,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.90970727,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"85","issue":"1","first_page":"82","last_page":"86"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9258000254631042,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9258000254631042,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13639","display_name":"Paraquat toxicity studies and treatments","score":0.03139999881386757,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10875","display_name":"Pesticide Exposure and Toxicity","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paraquat","display_name":"paraquat","score":0.9139999747276306},{"id":"https://openalex.org/keywords/nigrostriatal-degeneration","display_name":"nigrostriatal degeneration","score":0.8849999904632568},{"id":"https://openalex.org/keywords/dopaminergic-neurotoxicity","display_name":"dopaminergic neurotoxicity","score":0.8029999732971191},{"id":"https://openalex.org/keywords/l-dopa","display_name":"L-DOPA","score":0.7459999918937683},{"id":"https://openalex.org/keywords/amino-acid-transporters","display_name":"amino acid transporters","score":0.6420000195503235},{"id":"https://openalex.org/keywords/system-l","display_name":"system L","score":0.6909999847412109},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.9369999766349792},{"id":"https://openalex.org/keywords/valine","display_name":"valine","score":0.7860000133514404},{"id":"https://openalex.org/keywords/l-phenylalanine","display_name":"L-phenylalanine","score":0.996999979019165},{"id":"https://openalex.org/keywords/alpha-synuclein-aggregation","display_name":"alpha-synuclein aggregation","score":0.8360000252723694},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.8069999814033508},{"id":"https://openalex.org/keywords/herbicide-neurotoxicity","display_name":"herbicide neurotoxicity","score":0.8730000257492065},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.6660000085830688}],"concepts":[{"id":"https://openalex.org/C2776527163","wikidata":"https://www.wikidata.org/wiki/Q409669","display_name":"Paraquat","level":2,"score":0.9673547744750977},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6426315307617188},{"id":"https://openalex.org/C515207424","wikidata":"https://www.wikidata.org/wiki/Q8066","display_name":"Amino acid","level":2,"score":0.6361021399497986},{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.6121396422386169},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.5823318958282471},{"id":"https://openalex.org/C2779491297","wikidata":"https://www.wikidata.org/wiki/Q3338704","display_name":"Neurotoxicity","level":3,"score":0.5803014039993286},{"id":"https://openalex.org/C2777573094","wikidata":"https://www.wikidata.org/wiki/Q483752","display_name":"Valine","level":3,"score":0.54640132188797},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.5210127830505371},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.48350790143013},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.35219308733940125},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25743353366851807},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2184182107448578},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.18201029300689697},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000596","descriptor_name":"Amino Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003342","descriptor_name":"Corpus Striatum","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010269","descriptor_name":"Paraquat","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D010269","descriptor_name":"Paraquat","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D010302","descriptor_name":"Parkinson Disease, Secondary","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D014446","descriptor_name":"Tyrosine 3-Monooxygenase","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1471-4159.2003.01621.x","doi":"https://doi.org/10.1046/j.1471-4159.2003.01621.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.2003.01621.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:12641729","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12641729","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.8048999905586243,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1967056906","display_name":"Environmental, Genetic and Cellular Determinants of PD","funder_award_id":"U54ES012077","funder_id":"https://openalex.org/F4320337361","funder_display_name":"National Institute of Environmental Health Sciences"},{"id":"https://openalex.org/G5605766866","display_name":"SYNUCLEIN AGGREGATION AND NEURODEGENATION IN TRANSGENICS","funder_award_id":"R01ES010442","funder_id":"https://openalex.org/F4320337361","funder_display_name":"National Institute of Environmental Health Sciences"},{"id":"https://openalex.org/G8338454225","display_name":"INTERACTIONS BETWEEN ALPHA-SYNUCLEIN/METALS/PESTICIDES","funder_award_id":"R01ES010806","funder_id":"https://openalex.org/F4320337361","funder_display_name":"National Institute of Environmental Health Sciences"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337361","display_name":"National Institute of Environmental Health Sciences","ror":"https://ror.org/00j4k1h63"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1504584187","https://openalex.org/W1591724033","https://openalex.org/W1959399248","https://openalex.org/W1989108550","https://openalex.org/W2012667670","https://openalex.org/W2043230097","https://openalex.org/W2044156447","https://openalex.org/W2050786534","https://openalex.org/W2079536916","https://openalex.org/W2093221129","https://openalex.org/W2098128390","https://openalex.org/W2113634953","https://openalex.org/W2119258483","https://openalex.org/W2152525754","https://openalex.org/W2318440312"],"related_works":["https://openalex.org/W2044156447","https://openalex.org/W7146339144","https://openalex.org/W2054064910","https://openalex.org/W2386200873","https://openalex.org/W1542681400","https://openalex.org/W1987656015","https://openalex.org/W2043990301","https://openalex.org/W1977886577","https://openalex.org/W2058743009","https://openalex.org/W2065665245"],"abstract_inverted_index":{"Exposure":[0],"to":[1,23,138],"the":[2,14,30,35,40,65,71,113,121,124,153,165,169,195,215,220],"herbicide":[3],"paraquat":[4,27,52,58,89,183,198],"causes":[5],"selective":[6],"nigrostriatal":[7,102,221],"degeneration":[8],"and":[9,54,105,200],"aggregation":[10],"of":[11,19,26,37,39,67,79,101,107,157,164,192,217],"alpha-synuclein":[12],"in":[13,33,64,197],"mouse":[15],"brain.":[16],"The":[17],"purpose":[18],"this":[20],"study":[21],"was":[22,62,75,130,144],"assess":[24],"mechanisms":[25],"entry":[28],"into":[29],"CNS":[31],"and,":[32],"particular,":[34],"effects":[36,216],"substrates":[38],"blood-brain":[41],"barrier":[42],"(BBB)":[43],"neutral":[44,126,170],"amino":[45,94,127,171,206],"acid":[46,128,172],"transporter":[47],"(System":[48],"L":[49,85],"carrier)":[50],"on":[51],"accumulation":[53],"neurotoxicity.":[55],"Using":[56],"a":[57,162,189],"antibody,":[59],"robust":[60],"immunoreactivity":[61,74],"observed":[63],"midbrain":[66],"mice":[68],"injected":[69,177],"with":[70,92,151,160,178,188],"herbicide.":[72],"This":[73],"abolished":[76],"by":[77],"administration":[78],"l-valine":[80],"or":[81,159,174,208],"l-phenylalanine,":[82],"two":[83],"System":[84],"substrates,":[86],"immediately":[87],"before":[88],"exposure.":[90,184],"Pre-treatment":[91],"these":[93],"acids":[95],"completely":[96],"protected":[97],"against":[98],"paraquat-induced":[99,142],"loss":[100],"dopaminergic":[103],"cells":[104],"formation":[106],"thioflavine":[108],"S-positive":[109],"intracellular":[110],"deposits.":[111],"Interestingly,":[112],"anti-parkinsonian":[114],"drug":[115],"l-dopa,":[116],"which":[117],"is":[118],"transported":[119],"across":[120,194],"BBB":[122,196],"through":[123],"same":[125],"carrier,":[129,173],"also":[131],"neuroprotective":[132],"when":[133],"administered":[134],"30":[135],"min":[136],"prior":[137],"paraquat.":[139],"In":[140],"contrast,":[141],"toxicity":[143],"unaffected":[145],"if":[146],"animals":[147],"(i)":[148],"were":[149,176],"pre-treated":[150],"d-valine,":[152],"biologically":[154],"inactive":[155],"d-isomer":[156],"l-valine,":[158],"l-lysine,":[161],"substrate":[163],"basic":[166],"rather":[167],"than":[168],"(ii)":[175],"l-dopa":[179],"24":[180],"h":[181],"after":[182],"Data":[185],"are":[186],"consistent":[187],"critical":[190],"role":[191],"uptake":[193],"neurotoxicity,":[199],"suggest":[201],"that":[202],"dietary":[203],"elements":[204],"(e.g.":[205,211],"acids)":[207],"therapeutic":[209],"agents":[210],"l-dopa)":[212],"may":[213],"modify":[214],"toxicants":[218],"targeting":[219],"system.":[222]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1862857558","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":9},{"year":2013,"cited_by_count":10},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
